ong-term evaluation of SARS-CoV-2 antibody assays using mild symptomatik patients
- Conditions
- 07.1GU09.9G
- Registration Number
- DRKS00028039
- Lead Sponsor
- DiaSys Diagnostic Systems GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 21
Inclusion Criteria
mild COVID-19 symptoms and a positive result of SARS-CoV-2 RT-PCR in a nasopharyngeal swab and repeated antibody determinations over a longer period of time
Exclusion Criteria
hospitalisation, missing SARS-CoV-2 RT-PCR report, SARS-CoV-2 reinfection
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ong term evaluation of<br>1.) mild symptomatik patients up to the timepoint of the first vaccination<br>2.) vaccinated individuals up to 6 months after second vaccination
- Secondary Outcome Measures
Name Time Method not determined